Chronic myeloproliferative disorders.

Medicine & Life Sciences

• Myeloproliferative Disorders 100%
• Polycythemia Vera 99%
• Essential Thrombocythemia 71%
• Primary Myelofibrosis 66%
• Aspirin 27%
• Thalidomide 21%
• Phlebotomy 21%
• Erythrocyte Volume 17%
• Platelet Count 17%
• Megakaryocytes 14%
• Splenomegaly 13%
• Metaplasia 12%
• Therapeutics 12%
• Granulocytes 11%
• Messenger RNA 10%
• Pharmaceutical Preparations 9%
• Blood Platelets 9%
• Thrombosis 9%
• Thrombopoietin Receptors 8%
• Polycythemia 7%
• Philadelphia Chromosome 7%
• Alternative Splicing 6%
• Stem Cell Transplantation 6%
• Glycosylation 6%
• Hyperlipidemias 5%
• Natural History 5%
• Hematocrit 5%
• Leukocyte Count 5%
• Thrombocytopenia 5%
• Blood Proteins 5%
• Anemia 4%
• Single Nucleotide Polymorphism 4%
• Exons 4%
• Iron 4%
• Membrane Proteins 4%
• Leukemia 4%
• Neutrophils 4%
• Spleen 4%
• Stem Cells 4%
• Cell Membrane 4%
• Myocardial Infarction 4%
• Smoking 4%
• Obesity 4%
• Stroke 4%
• Hypertension 3%
• Hemorrhage 3%
• Antigens 3%
• Drug Therapy 3%
• Mutation 3%
• DNA 3%
• Mortality 2%